First European phase II trial of intravenous (iv) cetuximab (Cet) and hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil and oxaliplatin in patients with unresectable liver metastases from wt KRAS colorectal cancer (CRC) after systemic therapy failure (OPTILIV, NCT00852228)
Levi, Francis, Ducreux, Michel, Hebbar, Mohamed, Rougier, Philippe, Focan, C. N. J., Guimbaud, Rosine, Carvalho, Carlos, Tumolo, Salvatore, Innominato, Pasquale F., Ajavon, Yves, Castaing, Denis, De Baere, Thierry, Karaboué, Abdoulaye, Lepere, Celine, Boige, Valerie, Proux, Laetitia, Adam, Rene, Bouchahda, Mohamed
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article